Patent · US Active

Methods of inhibiting cataracts and presbyopia

US9789091B2 · kind B2 · utility

2Cited by

26References

24Claims

0Family size

Assignee

University of Massachusetts · US

Inventors

Murugappan Muthukumar · Amherst, US
Benjamin Mohr · Ludwigshafen, DE

Key dates

Filing date	Mar 14, 2014
Grant date	Oct 17, 2017
Priority date	—
Expiry date	Mar 14, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P27/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein are methods of inhibiting or reversing the progression of cataract formation or presbyopia in an eye by administering a γ-crystallin charge masking agent. Both presbyopia and cataracts are caused by aggregation of the soluble crystalline lens proteins called the crystallins.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.